{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:44:09Z","timestamp":1779335049822,"version":"3.51.4"},"reference-count":38,"publisher":"American Diabetes Association","issue":"5","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK094176"],"award-info":[{"award-number":["U01 DK094176"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK094157"],"award-info":[{"award-number":["U01 DK094157"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Individuals with diabetes have higher resting heart rate compared with those without, which may be predictive of long-term cardiovascular disease (CVD) risk. Using data from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study, we evaluated whether the beneficial effect of intensive versus conventional diabetes therapy on heart rate persisted, the factors mediating the differences in heart rate between treatment groups, and the effects of heart rate on future CVD risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Longitudinal changes in heart rate, from annual electrocardiograms over 22 years of EDIC follow-up, were evaluated in 1,402 participants with type 1 diabetes. Linear mixed models were used to assess the effect of DCCT treatment group on mean heart rate over time, and Cox proportional hazards models were used to estimate the effect of heart rate on CVD risk during DCCT\/EDIC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>At DCCT closeout, 52% of participants were male and mean \u00b1 SD age was 33 \u00b1 7 years, diabetes duration 12 \u00b1 5 years, and HbA1c 7.4 \u00b1 1.2% (intensive) and 9.1 \u00b1 1.6% (conventional). Through EDIC, participants in the intensive group had significantly lower heart rate in comparison with the conventional group. While significant group differences in heart rate were fully attenuated by DCCT\/EDIC mean HbA1c, higher heart rate predicted CVD and major adverse cardiovascular events independent of other risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>After 22 years of follow-up, former intensive versus conventional therapy remained significantly associated with lower heart rate, consistent with the long-term beneficial effects of intensive therapy on CVD. DCCT treatment group effects on heart rate were explained by differences in DCCT\/EDIC mean HbA1c.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc20-2387","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:30:12Z","timestamp":1614299412000},"page":"1125-1132","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":10,"title":["Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT\/EDIC Study"],"prefix":"10.2337","volume":"44","author":[{"given":"Sareh","family":"Keshavarzi","sequence":"first","affiliation":[{"name":"The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2184-9754","authenticated-orcid":false,"given":"Barbara H.","family":"Braffett","sequence":"additional","affiliation":[{"name":"The Biostatistics Center, Milken Institute School of Public Health, The George Washington University, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2042-1350","authenticated-orcid":false,"given":"Rodica","family":"Pop-Busui","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor J.","family":"Orchard","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5632-8150","authenticated-orcid":false,"given":"Elsayed Z.","family":"Soliman","sequence":"additional","affiliation":[{"name":"Wake Forest School of Medicine, Winston-Salem, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayle M.","family":"Lorenzi","sequence":"additional","affiliation":[{"name":"University of California, San Diego, La Jolla, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Barnie","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy B.","family":"Karger","sequence":"additional","affiliation":[{"name":"University of Minnesota, Minneapolis, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7376-6870","authenticated-orcid":false,"given":"Rose A.","family":"Gubitosi-Klug","sequence":"additional","affiliation":[{"name":"Case Western Reserve University and University Hospitals Rainbow Babies and Children\u2019s Hospital, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5318-9677","authenticated-orcid":false,"given":"Samuel","family":"Dagogo-Jack","sequence":"additional","affiliation":[{"name":"University of Tennessee Health Science Center, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Paterson","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the DCCT\/EDIC Research Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"2022031309513184200_B1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc07-0874","article-title":"Resting heart rate in middle age and diabetes development in older age","volume":"31","author":"Carnethon","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ajh.2008.331","article-title":"Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population","volume":"22","author":"Shigetoh","year":"2009","journal-title":"Am J Hypertens"},{"key":"2022031309513184200_B3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/heartjnl-2015-309119","article-title":"The association between resting heart rate and type 2 diabetes and hypertension in Korean adults","volume":"102","author":"Kim","year":"2016","journal-title":"Heart"},{"key":"2022031309513184200_B4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","article-title":"Resting heart rate in cardiovascular disease","volume":"50","author":"Fox","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022031309513184200_B5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am Heart J"},{"key":"2022031309513184200_B6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","article-title":"Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease","volume":"26","author":"Diaz","year":"2005","journal-title":"Eur Heart J"},{"key":"2022031309513184200_B7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"2022031309513184200_B8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/oxfordjournals.aje.a113046","article-title":"Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies","volume":"112","author":"Dyer","year":"1980","journal-title":"Am J Epidemiol"},{"key":"2022031309513184200_B9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"B\u00f6hm","year":"2010","journal-title":"Lancet"},{"key":"2022031309513184200_B10","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/eurheartj\/ehs449","article-title":"Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease","volume":"34","author":"Johansen","year":"2013","journal-title":"Eur Heart J"},{"key":"2022031309513184200_B11","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2337\/dc06-1441","article-title":"The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study","volume":"30","author":"Paterson","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B12","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db15-1517","article-title":"Risk factors for cardiovascular disease in type 1 diabetes","volume":"65","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group","year":"2016","journal-title":"Diabetes"},{"key":"2022031309513184200_B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.10.1.1","article-title":"Diabetes Control and Complications Trial (DCCT): results of feasibility study","volume":"10","author":"The DCCT Research Group","year":"1987","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"2022031309513184200_B15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/diacare.22.1.99","article-title":"Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort","volume":"22","author":"The DCCT\/EDIC Research Group","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1373\/clinchem.2004.042143","article-title":"Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study","volume":"51","author":"Steffes","year":"2005","journal-title":"Clin Chem"},{"key":"2022031309513184200_B17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2022031309513184200_B18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2215\/CJN.07901109","article-title":"Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study","volume":"5","author":"Younes","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022031309513184200_B19","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/CIRCULATIONAHA.108.837369","article-title":"Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study (DCCT\/EDIC)","volume":"119","author":"Pop-Busui","year":"2009","journal-title":"Circulation"},{"key":"2022031309513184200_B20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2337\/dc16-1397","article-title":"Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B21","volume-title":"The Minnesota Code Manual of Electrocardiographic Findings: Standard and Procedures for Measurement and Classification","author":"Prineas","year":"1982"},{"key":"2022031309513184200_B22","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"2022031309513184200_B23","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","article-title":"Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus","volume":"287","author":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2002","journal-title":"JAMA"},{"key":"2022031309513184200_B24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview","volume":"37","author":"Nathan DM; DCCT\/EDIC Research Group","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2337\/dc16-0502","article-title":"Coprogression of cardiovascular risk factors in type 1 diabetes during 30 years of follow-up in the DCCT\/EDIC study","volume":"39","author":"Writing Group for the DCCT\/EDIC Research Group","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11892-010-0120-8","article-title":"DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history","volume":"10","author":"Pop-Busui","year":"2010","journal-title":"Curr Diab Rep"},{"key":"2022031309513184200_B27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/db14-0930","article-title":"Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT\/EDIC","volume":"64","author":"Lachin","year":"2015","journal-title":"Diabetes"},{"key":"2022031309513184200_B29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S2213-8587(14)70155-X","article-title":"Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study","volume":"2","author":"DCCT\/EDIC Research Group","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031309513184200_B30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12265-012-9367-6","article-title":"What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes","volume":"5","author":"Pop-Busui","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"2022031309513184200_B32","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.2337\/dc12-2661","article-title":"The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT\/EDIC study","volume":"36","author":"Orchard","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s42255-020-0231-8","article-title":"DNA methylation mediates development of HbA1c-associated complications in type 1 diabetes","volume":"2","author":"Chen","year":"2020","journal-title":"Nat Metab"},{"key":"2022031309513184200_B34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/db19-1046","article-title":"Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"69","author":"Braffett","year":"2020","journal-title":"Diabetes"},{"key":"2022031309513184200_B35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00125-012-2471-y","article-title":"Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus","volume":"55","author":"Hillis","year":"2012","journal-title":"Diabetologia"},{"key":"2022031309513184200_B36","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2337\/dc18-1613","article-title":"Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT\/EDIC study","volume":"42","author":"Bebu","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031309513184200_B37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2337\/db18-0515","article-title":"Risk factor modeling for cardiovascular disease in type 1 diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) study: a comparison with the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study (DCCT\/EDIC)","volume":"68","author":"Miller","year":"2019","journal-title":"Diabetes"},{"key":"2022031309513184200_B38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0091-7435(76)90039-6","article-title":"The hypertension detection and follow-up program: hypertension detection and follow-up program cooperative group","volume":"5","year":"1976","journal-title":"Prev Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc20-2387","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/5\/1125\/632731\/dc202387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/5\/1125\/632731\/dc202387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T10:58:40Z","timestamp":1647169120000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/44\/5\/1125\/138747\/Risk-Factors-for-Longitudinal-Resting-Heart-Rate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,2,25]]},"published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc20-2387","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]}}}